3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
31
Hodgkin Disease
19
Lymphoma
9
Uveal Melanoma
5
Neoplasms
4
Sarcoma
3
Neoplasm Metastasis
3
Leiomyosarcoma
3
Skin Neoplasms
2
Skin Diseases
1
Sarcoma, Synovial
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neurofibrosarcoma
1
Lymphoma, T-Cell, Peripheral
1
Hematologic Diseases
1
HIV Infections
1
Interventions
Octreotide
5
Everolimus
4
pasireotide
3
lanreotide
3
ganitumab
2
gallium Ga 68 dotatate
2
cabozantinib
2
Nivolumab
2
Erlotinib Hydrochloride
2
surufatinib
1
pertuzumab
1
nintedanib
1
ibrutinib
1
fosbretabulin
1
conatumumab
1
cixutumumab
1
carfilzomib
1
arginyllysine
1
aflibercept
1
Temozolomide
1
Sunitinib
1
Somatostatin
1
Random Allocation
1
Ramucirumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Capecitabine
1
Bevacizumab
1
Axitinib
1
(18F)GTP1
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoid Tumor
×
Dacarbazine
×
Clear all
No trials found.